Joel A Sincavage

Array ( [id] => 6447439 [patent_doc_number] => 20100144837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 12/625871 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14419 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144837.pdf [firstpage_image] =>[orig_patent_app_number] => 12625871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579742 [patent_doc_number] => 20110293625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'INHIBITION OF VEGF-A SECRETION, ANGIOGENESIS AND/OR NEOANGIOGENESIS BY SINA MEDIATED KNOCKDOWN OF VEGF-C AND RHOA' [patent_app_type] => utility [patent_app_number] => 13/130699 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18277 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293625.pdf [firstpage_image] =>[orig_patent_app_number] => 13130699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536300 [patent_doc_number] => 20100124547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR VII GENES' [patent_app_type] => utility [patent_app_number] => 12/616828 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25298 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124547.pdf [firstpage_image] =>[orig_patent_app_number] => 12616828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6358752 [patent_doc_number] => 20100087334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'siRNA targeting superoxide dismutase 1 (SOD1)' [patent_app_type] => utility [patent_app_number] => 12/589879 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34504 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087334.pdf [firstpage_image] =>[orig_patent_app_number] => 12589879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22402 [patent_doc_number] => 07799764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Modulation of HIF1-beta expression' [patent_app_type] => utility [patent_app_number] => 12/578468 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30340 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799764.pdf [firstpage_image] =>[orig_patent_app_number] => 12578468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639845 [patent_doc_number] => 20100036107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'RNA INTERFERENCE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/578035 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24350 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20100036107.pdf [firstpage_image] =>[orig_patent_app_number] => 12578035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6232037 [patent_doc_number] => 20100184835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of Sirna' [patent_app_type] => utility [patent_app_number] => 12/575752 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25875 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184835.pdf [firstpage_image] =>[orig_patent_app_number] => 12575752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343904 [patent_doc_number] => 20100330152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'METHODS AND COMPOSITONS FOR ANTISENSE VEGF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/573849 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24484 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330152.pdf [firstpage_image] =>[orig_patent_app_number] => 12573849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682184 [patent_doc_number] => 20100022624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Methods of Treating Smooth Muscle Cell Disorders' [patent_app_type] => utility [patent_app_number] => 12/567500 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31896 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022624.pdf [firstpage_image] =>[orig_patent_app_number] => 12567500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561868 [patent_doc_number] => 20110275701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'ANTI-THROMBIN APTAMER FORMULATIONS AND METHODS FOR USE' [patent_app_type] => utility [patent_app_number] => 13/119826 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25076 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275701.pdf [firstpage_image] =>[orig_patent_app_number] => 13119826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9574964 [patent_doc_number] => 08765376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-01 [patent_title] => 'Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator' [patent_app_type] => utility [patent_app_number] => 13/063333 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25852 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294613 [patent_doc_number] => 08222395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'siRNA targeting kinase insert domain receptor (KDR)' [patent_app_type] => utility [patent_app_number] => 12/584352 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 35526 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12584352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592849 [patent_doc_number] => 20100130589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'MODULATION OF eIF4E EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/550479 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52510 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130589.pdf [firstpage_image] =>[orig_patent_app_number] => 12550479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592964 [patent_doc_number] => 20100130595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/547474 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32302 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130595.pdf [firstpage_image] =>[orig_patent_app_number] => 12547474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451255 [patent_doc_number] => 07964579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Compositions and methods for topical delivery of oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/545778 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21927 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964579.pdf [firstpage_image] =>[orig_patent_app_number] => 12545778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627345 [patent_doc_number] => 20100004142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'siRNA targeting myeloid cell Leukemia sequence 1' [patent_app_type] => utility [patent_app_number] => 12/463000 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 28961 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004142.pdf [firstpage_image] =>[orig_patent_app_number] => 12463000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6543255 [patent_doc_number] => 20100016176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'siRNA targeting histamine receptor H1' [patent_app_type] => utility [patent_app_number] => 12/462820 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35487 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016176.pdf [firstpage_image] =>[orig_patent_app_number] => 12462820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389339 [patent_doc_number] => 08685937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Nucleic acid aptamers' [patent_app_type] => utility [patent_app_number] => 13/057443 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 32923 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465844 [patent_doc_number] => 20090326044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'RNAi-Mediated Inhibition of Ocular Targets' [patent_app_type] => utility [patent_app_number] => 12/536698 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19148 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326044.pdf [firstpage_image] =>[orig_patent_app_number] => 12536698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627326 [patent_doc_number] => 20100004141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'siRNA targeting polo-like Kinase-1 (PLK-1)' [patent_app_type] => utility [patent_app_number] => 12/460876 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35053 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004141.pdf [firstpage_image] =>[orig_patent_app_number] => 12460876 [rel_patent_id] =>[rel_patent_doc_number] =>)